# Frederic Caux – FDA 483, Jun 6, 2025

Source: https://www.keypedia.com/records/483/frederic-caux/0bd35f7b-c448-47d4-8f35-418d66c27b25

> FDA 483 for Frederic Caux on June 06, 2025. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Frederic Caux
- Inspection Date: 2025-06-06
- Product Type: drugs
- Office Name: Division of Clinical Evidence and Analysis 1 (Clinical Policy and Quality)
- Summary: Frederic Caux, a clinical investigator in Bobigny, France, was cited for failing to prepare or maintain accurate case histories during an inspection. Specifically, the investigator did not report a subject's required rescue treatment with a high-potency topical corticosteroid cream for a Bullous Pemphigoid relapse to the study sponsor. This indicates a failure in data capture and adherence to protocol requirements.

## Related Officers

- [Kristin M. Abaonza](https://www.keypedia.com/people/kristin-m-abaonza/cf909da8-837d-4dfe-9ccc-288b24d7bba3)
- [Director](https://www.keypedia.com/people/joann-m/0a459cd4-7849-4687-8811-4868144e3be3)
- [President at Genpact](https://www.keypedia.com/people/damon-a-growl/b2827f8c-e454-4db3-9285-07d11b964d5a)

Company: https://www.keypedia.com/companies/frederic-caux/5008dafd-1306-4208-8f0f-0e13a848675b

Office: https://www.keypedia.com/offices/division-of-clinical-evidence-and-analysis-1-clinical-policy-and-quality/5f95da17-30bb-423f-b892-5ea041823fbd